XBIO
Xenetic Biosciences·NASDAQ
--
--(--)
--
--(--)
3.38 / 10
Netural
Fund flow metrics register a healthy 6.75/10, indicating robust capital movement; Small and Large inflows are positive, though overall and Medium flows show negative trends. Analyst sentiment is uniformly neutral (100%) with no historical win rate data. The divergence between positive fund flows and neutral analyst views underscores the need for vigilance—capital may be rotating in anticipation of news, but without strong analyst conviction, downside risks persist.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-04-09
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate0.0%
What is the market sentiment for XBIO?
- XBIO holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.38/10 (Netural).
